EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $212,000 | -95.7% | 4,227 | -94.6% | 0.00% | -100.0% |
| Q2 2021 | $4,918,000 | -88.1% | 78,079 | -82.4% | 0.00% | -88.2% |
| Q1 2021 | $41,155,000 | +4.4% | 442,962 | +0.6% | 0.02% | 0.0% |
| Q4 2020 | $39,435,000 | -6.4% | 440,117 | +8.0% | 0.02% | -15.0% |
| Q3 2020 | $42,112,000 | +10.1% | 407,556 | +0.1% | 0.02% | 0.0% |
| Q2 2020 | $38,258,000 | +62.1% | 407,089 | -0.2% | 0.02% | +25.0% |
| Q1 2020 | $23,605,000 | +1.9% | 407,973 | -5.0% | 0.02% | +33.3% |
| Q4 2019 | $23,173,000 | +3.0% | 429,531 | -0.2% | 0.01% | 0.0% |
| Q3 2019 | $22,492,000 | +19.5% | 430,226 | +10.4% | 0.01% | +20.0% |
| Q2 2019 | $18,818,000 | +79.6% | 389,534 | +87.9% | 0.01% | +66.7% |
| Q1 2019 | $10,475,000 | – | 207,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |